demonstr
figur
hepat
level
mrna
significantli
higher
pbc
psc
healthi
control
subject
hepat
mrna
also
increas
psc
pbc
patient
wherea
signific
differ
seen
mrna
express
either
patient
group
western
blot
analysi
confirm
protein
express
increas
cholestat
liver
tissu
compar
healthi
control
subject
figur
previou
report
shown
serum
level
increas
patient
pbc
togeth
find
suggest
inflammasom
play
role
pathogenesi
human
cholestat
liver
injuri
examin
function
role
inflammasom
cholestat
liver
injuri
perform
bdl
wt
mice
day
demonstr
figur
rna
express
increas
wt
bdl
liver
compar
sham
control
subject
howev
cleav
kd
found
wt
bdl
liver
figur
indic
inflammasom
activ
wt
cholestat
mice
defici
protein
pro
cleav
form
liver
confirm
inflammasom
activ
mice
bdl
day
plasma
level
liver
enzym
alanin
aminotransferas
alt
alkalin
phosphatas
alp
significantli
lower
mice
wt
bdl
group
figur
plasma
elev
wt
mice
mice
bdl
contrast
bile
acid
level
plasma
figur
liver
elev
bdl
compar
sham
control
subject
differ
wt
mice
day
bdl
data
shown
blind
assess
liver
hematoxylin
eosin
histolog
reveal
signific
differ
necrosi
bile
duct
prolifer
inflammatori
infiltr
group
day
bdl
paradox
hepat
fibrosi
increas
mice
figur
later
find
confirm
siriu
stain
liver
section
measur
hepat
hydroxyprolin
content
western
blot
smooth
muscl
actin
protein
liver
bdl
figur
togeth
find
indic
inflammasom
may
activ
cholestat
liver
absenc
reduc
hepat
injuri
degre
increas
liver
fibrosi
gain
insight
natur
pathogen
role
inflammasom
cholestat
liver
analyz
hepat
express
addit
gene
involv
inflamm
fibrosi
bile
acid
homeostasi
shown
figur
bdl
led
mark
increas
mrna
express
wt
liver
increas
mice
significantli
higher
wt
bdl
group
confirm
increas
fibrot
activ
bdl
liver
howev
hepat
mrna
express
gene
involv
maintain
bile
acid
homeostasi
substanti
differ
wt
group
bdl
includ
nuclear
receptor
bile
acid
transport
bile
acid
synthesi
enzym
also
differ
seen
mrna
level
mrna
group
either
figur
data
shown
determin
whether
loss
inflammasom
alter
profil
hepat
immun
cell
first
measur
mrna
express
cell
marker
gene
ie
elan
neutrophil
cell
macrophag
differ
elan
express
wt
group
day
bdl
bdl
liver
significantli
higher
amount
detect
wt
bdl
liver
figur
indic
macrophagekupff
cell
absenc
inflammasom
activ
confirm
observ
perform
immunohistochemistri
liver
section
wt
bdl
liver
shown
figur
posit
area
liver
wt
liver
bdl
character
hepat
macrophag
kupffer
cell
phenotyp
mice
analyz
mrna
express
marker
differenti
pro
antiinflammatori
type
ie
respect
includ
arginas
found
bdl
result
signific
decreas
express
antiinflammatori
cytokin
howev
decreas
significantli
less
bdl
liver
wt
bdl
liver
figur
suggest
antiinflammatori
macrophag
bdl
liver
higher
express
level
macrophag
marker
ie
also
found
bdl
liver
wt
bdl
liver
consist
higher
number
macrophag
former
figur
differ
mrna
express
among
group
presum
normal
abundantli
express
hepatocyt
immunofluoresc
label
hepat
anoth
macrophag
marker
confirm
macrophag
bdl
liver
wt
bdl
liver
figur
togeth
find
suggest
normal
function
inflammasom
activ
proinflammatori
seen
wt
bdl
mice
absenc
inflammasom
activ
partial
convers
proinflammatori
antiinflammatori
environ
respect
macrophag
phenotyp
seen
bdl
liver
investig
whether
bile
acid
activ
inflammasom
isol
hepat
parenchym
cell
periton
macrophag
mice
hepatocyt
treat
taurochol
acid
tca
major
endogen
bile
acid
mice
hour
mrna
express
chemokin
markedli
increas
previous
report
figur
mrna
express
remain
undetect
cell
defici
alter
tca
induct
mous
hepatocyt
figur
addit
western
blot
analysi
detect
cleavag
wt
mous
hepatocyt
expos
tca
high
end
pathophysiolog
relev
concentr
lipopolysaccharid
lp
adenosin
triphosph
atp
hour
figur
indic
inflammasom
activ
hepatocyt
measur
furthermor
glycochol
acid
anoth
major
endogen
bile
acid
tauroursodeoxychol
acid
treatment
also
caus
cleavag
mous
hepatocyt
contrast
increas
protein
express
cleavag
found
mous
macrophag
cultur
expos
lp
atp
indic
inflammasom
activ
cell
posit
control
howev
tca
treatment
alon
combin
lp
atp
increas
neither
protein
express
cleavag
figur
report
examin
role
inflammasom
cholestat
liver
injuri
human
mice
determin
whether
bile
acid
activ
inflammasom
hepatocyt
macrophag
cholestat
condit
found
hepat
express
inflammasom
gene
mrna
protein
increas
cholestat
patient
pbc
psc
figur
increas
express
activ
inflammasom
gene
also
seen
cholestat
mous
liver
bdl
figur
lack
inflammasom
activ
mice
reduc
marker
cholestat
hepat
injuri
alt
alp
increas
liver
fibrosi
bdl
figur
defici
mice
also
promot
increas
macrophag
phenotyp
liver
bdl
thu
presum
partial
convert
proinflammatori
phenotyp
antiinflammatori
state
figur
pathophysiolog
concentr
major
endogen
bile
acid
tca
activ
inflammasom
mous
hepatocyt
macrophag
figur
therefor
conclud
inflammasom
activ
cholestat
liver
contribut
injuri
activ
appear
occur
direct
action
bile
acid
like
activ
involv
macrophag
rather
hepatocyt
liver
role
inflammasom
pathogenesi
differ
diseas
often
conflict
inflammasom
signal
report
protect
liver
hepat
tumor
growth
viru
infect
increas
surviv
rate
respons
hepat
parasit
load
trypanosoma
cruzi
contrast
inflammasom
contribut
pathogenesi
alcohol
liver
diseas
present
studi
found
inflammasom
inde
activ
cholestat
liver
loss
inflammasom
activ
mice
reduc
acut
manifest
hepat
injuri
alt
alp
without
signific
alter
liver
necrosi
bile
duct
prolifer
gross
estim
inflamm
paradox
enhanc
liver
fibrosi
fibrogenesi
consid
part
process
tissu
heal
follow
inflammatori
injuri
may
conclud
deactiv
inflammasom
cholestasi
block
proinflammatori
properti
suggest
activ
role
would
consist
seen
liver
disord
alcohol
liver
diseas
hypothesi
consist
increas
macrophag
liver
bdl
mice
reflect
higher
express
marker
gene
figur
increas
known
lead
stimul
express
classic
profibrot
would
explain
fibrosi
increas
bdl
liver
illustr
figur
reduc
hepat
injuri
seen
bdl
mice
absenc
inflammasom
also
consist
sever
earlier
report
deplet
macrophag
attenu
liver
injuri
rodent
model
recent
studi
indic
elev
hepat
level
bile
acid
initi
inflammatori
respons
stimul
cytokin
express
thu
reason
specul
bile
acid
might
activ
inflammasom
cholestat
liver
howev
find
support
hypothesi
indic
bile
acid
directli
activ
inflammasom
hepatocyt
macrophag
kupffer
cell
concentr
pathophysiolog
relev
previou
studi
support
hypothesi
use
hydrophob
bile
acid
speci
chenodeoxychol
acid
lithochol
acid
high
concentr
seen
cholestat
patient
anim
model
thu
like
artifact
vitro
major
speci
endogen
bile
acid
conjug
bile
acid
requir
bile
acid
transport
protein
enter
cell
transport
seen
hepat
parenchym
cell
absent
macrophag
hepat
cell
unconjug
bile
acid
diffus
cell
never
reach
pathophysiolog
mechan
inflammasom
activ
cholestat
liver
remain
determin
specul
relat
welldescrib
inflammatori
respons
gener
hepatocyt
induc
hepat
retent
bile
hepat
parenchym
cell
undergo
necrosi
cholestasi
alarmin
eg
atp
damageassoci
molecular
pattern
releas
die
cell
would
trigger
activ
inflammasom
hepat
macrophag
kupffer
cell
orchestr
immun
respons
contribut
liver
shown
figur
summari
found
inflammasom
play
role
cholestat
liver
injuri
bile
acid
directli
activ
inflammasom
base
find
specul
activ
inflammasom
cholestasi
secondari
bile
inflammatori
injuri
site
activ
macrophag
chemic
purchas
sigmaaldrich
st
loui
mo
except
otherwis
specifi
cell
cultur
media
william
e
dulbecco
modifi
eagl
medium
heatinactiv
fetal
bovin
serum
penicillin
streptomycin
trypsin
phosphatebuff
salin
enhanc
chemiluminesc
reagent
obtain
thermofish
scientif
waltham
mous
protein
quantif
enzymelink
immunosorb
assay
elisa
kit
purchas
r
system
minneapoli
mn
anim
studi
review
approv
board
institut
anim
care
use
committe
yale
univers
wholebodi
gene
knockout
mice
background
describ
previou
wildtyp
mice
purchas
jackson
laboratori
bar
harbor
anim
kept
pathogenfre
environ
control
lightdark
regim
anim
facil
yale
univers
bile
duct
ligat
sham
oper
perform
mice
day
previous
overnight
fast
mice
sacrif
plasma
liver
collect
biochem
molecular
biolog
analys
tissu
snapfrozen
liquid
nitrogen
store
histolog
assess
liver
section
fix
formalin
embed
paraffin
hepatocyt
nonparenchym
cell
isol
mice
use
collagenas
perfus
hepatocyt
maintain
collagen
sandwich
cultur
close
resembl
vivo
condit
mous
periton
macrophag
isol
previous
maintain
dulbecco
modifi
eagl
medium
contain
fetal
bovin
serum
cell
cultur
treat
indic
chemic
collect
within
hour
isol
liver
specimen
acquir
liver
tissu
cell
distribut
system
univers
minnesota
fund
nation
institut
health
contract
includ
normal
healthi
control
subject
deceas
donor
whose
liver
suitabl
transplant
pbc
psc
patient
underw
liver
transplant
plasma
level
liver
enzym
bile
acid
assay
formalinfix
liver
tissu
middl
portion
largest
lobe
anim
paraffin
embed
section
stain
hematoxylin
eosin
liver
section
also
stain
siriu
red
fibrosi
evalu
liver
histolog
blindli
assess
necrosi
bile
duct
prolifer
fibrosi
inflamm
scale
immunohistochemistri
stain
immunofluoresc
label
liver
section
perform
previous
specif
immunohistochemistri
stain
monoclon
antibodi
mous
cat
cell
signal
technolog
danver
dilut
use
probe
deparaffin
section
randomli
select
anim
bdl
group
six
imag
randomli
taken
across
section
magnif
use
olympu
olympu
corp
japan
microscop
imagej
softwar
nation
institut
health
bethesda
md
use
calcul
positivesign
area
immunofluoresc
label
monoclon
antibodi
cat
biorad
hercul
ca
dilut
incub
frozen
liver
section
randomli
select
anim
bdl
group
five
imag
randomli
taken
across
section
magnif
use
zeiss
carl
zeiss
microscopi
llc
white
plain
ny
fluoresc
microscop
count
posit
cell
imag
field
assess
blind
fashion
liver
hydroxyprolin
content
assay
previous
tissu
rna
protein
extract
assay
primer
probe
set
taqman
assay
purchas
thermofish
scientif
antibodi
gapdh
western
blot
sigmaaldrich
antibodi
mous
adipogen
life
scienc
san
diego
ca
cat
adipogen
life
scienc
cat
r
system
cat
human
cell
signal
technolog
cat
purchas
indic
vendor
use
dilut
bovin
serum
albumin
quantit
polymeras
chain
reaction
western
blot
data
normal
correspond
level
gapdh
data
present
mean
sd
differ
experiment
group
assess
signific
use
analysi
varianc
twotail
student
test
use
calcul
p
valu
p
valu
consid
statist
signific
